Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE) | JACC

In this video interview, JACC Associate Editor Oyere Onuma, MD, FACC, speaks with author Philip Joseph, MD, on his paper published in JACC concerning trends in the use of secondary prevention medications for cardiovascular disease. The study and interview focuses on the work to increase the use of cardiovascular medications in patients with cardiovascular disease or risk, and the differences in high-, middle-, and low-income countries.